QHSLab, Inc. (USAQ) has a market capitalization of $7M. It is classified as a small-cap stock.
QHSLab, Inc. (USAQ) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 13.85%.
QHSLab, Inc. (USAQ) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
QHSLab, Inc. (USAQ) reported annual revenue of $3 million in its most recent fiscal year, based on SEC EDGAR filings.
QHSLab, Inc. (USAQ) has a net profit margin of 17.0%. This is a healthy margin.
QHSLab, Inc. (USAQ) generated $178 thousand in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
QHSLab, Inc. (USAQ) has a debt-to-equity ratio of 0.14. This indicates a conservatively financed balance sheet.
We are a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) and other healthcare providers to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. In some cases, the products we provide our physician clients will enable them to diagnose and treat patients with chronic diseases which they historically have referred to specialists, allowing them to increase their practice revenue. As part of our mission, we are providing PCPs and other healthcare providers with the software, training and devices necessary to allow them to treat their patients using value-based healthcare, informatics and personalized medicine.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.7M | 2.7M | 2.1M | 1.4M | 1.2M | 1.4M |
| Net Income | 457K | 457K | -259K | -468K | -996K | -770K |
| EPS | $0.02 | $0.02 | $-0.03 | $-0.05 | $-0.11 | $-0.10 |
| Free Cash Flow | 178K | 178K | 142K | -160K | -388K | -509K |
| ROIC | 26.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross Margin | 67.3% | 67.3% | 63.7% | 56.3% | 49.8% | 47.4% |
| Debt/Equity | 0.14 | 0.14 | -2.40 | -4.77 | 25.32 | 1.75 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | 131K | 131K | 206K | -240K | -561K | -502K |
| Operating Margin | 4.9% | 4.9% | 9.7% | -17.0% | -45.1% | -35.5% |
| ROE | 28.1% | 89.9% | 52.7% | 312.9% | -221.3% | -93.5% |
| Shares Outstanding | 23M | 23M | 9M | 9M | 9M | 8M |
| Metric | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | N/A | 1.4M | 1.2M | 1.4M | 2.1M | 2.7M | 2.7M |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 47.4% | 49.8% | 56.3% | 63.7% | 67.3% | 67.3% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | 98K | 91K | 190K | 214K | 294K | 485K | 485K |
| SG&A | 54K | 68K | N/A | 61K | 29K | 38K | 132K | 454K | 388K | 259K | 276K | 439K | 439K |
| EBIT | -54K | -68K | -61K | -61K | -29K | -722K | -275K | -502K | -561K | -240K | 206K | 131K | 131K |
| Op. Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -35.5% | -45.1% | -17.0% | 9.7% | 4.9% | 4.9% |
| Net Income | -63K | -77K | -70K | -70K | -40K | -722K | -327K | -770K | -996K | -468K | -259K | 457K | 457K |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -54.5% | -80.1% | -33.2% | -12.2% | 17.0% | 17.0% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||||||||||
| ROIC | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 26.7% |
| ROE | 40.2% | 33.0% | N/A | 18.7% | 10.3% | 165.3% | 63.1% | -93.5% | -221.3% | 312.9% | 52.7% | 89.9% | 28.1% |
| ROA | N/A | N/A | N/A | N/A | N/A | N/A | -202.0% | -61.5% | -47.8% | -25.7% | -14.9% | 23.0% | 21.1% |
| Cash Flow | |||||||||||||
| Op. Cash Flow | 0 | -3K | 0 | -12K | -18K | -38K | -166K | -355K | -351K | -160K | 142K | 178K | 178K |
| Free Cash Flow | N/A | -3K | N/A | -12K | -18K | -38K | -197K | -509K | -388K | -160K | 142K | 178K | 178K |
| Owner Earnings | 0 | -3K | 0 | -12K | -18K | -38K | -173K | -426K | -509K | -312K | -4K | 87K | 87K |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 32K | 155K | 37K | 0 | 0 | 0 | 0 |
| Maint. CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36K | 128K | 147K | 147K | 91K | 91K |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 119K | 0 | N/A | N/A | N/A | 0 |
| D&A | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36K | 128K | 147K | 147K | 91K | 91K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30K | 50K | 0 | 0 | 950K | 950K |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 13.9% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | 7K | 36K | 30K | 6K | 0 | 0 | 0 |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 179K | 380K | 359K | 194K | 90K | 90K |
| Balance Sheet | |||||||||||||
| Net Debt | N/A | N/A | N/A | N/A | N/A | N/A | 537K | 1.2M | 1.8M | 1.7M | 1.3M | -411K | -411K |
| Cash & Equiv. | 0 | 0 | N/A | 0 | 0 | 0 | 94K | 287K | 179K | 52K | 157K | 636K | 636K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | 576K | 644K | 426K | 12K | 31K | 91K | 91K |
| Debt/Equity | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.00 | -1.04 | 1.75 | 25.32 | -4.77 | -2.40 | 0.14 | 0.14 |
| Interest Coverage | -5.9 | -7.4 | -6.6 | -6.7 | -2.5 | -62.9 | -8.9 | -2.0 | -1.3 | -1.0 | 0.4 | 0.6 | 0.6 |
| Equity | -156K | -233K | -303K | -373K | -413K | -460K | -608K | 824K | 76K | -376K | -608K | 1.6M | 1.6M |
| Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 298K | 2.2M | 2.0M | 1.7M | 1.8M | 2.2M | 2.2M |
| Total Liabilities | 156K | 233K | 303K | 373K | 413K | 460K | 906K | 1.4M | 1.9M | 2.1M | 2.4M | 546K | 546K |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 1.6M | 1.5M | 1.4M | 1.4M | 1.3M | 1.3M |
| Retained Earnings | -202K | -280K | -349K | -419K | -459K | -1.2M | -1.7M | -2.5M | -3.5M | -4.0M | -4.3M | -3.9M | -3.9M |
| Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | 52K | -429K | -1.4M | -1.9M | -2.0M | 433K | 433K |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 266K | 446K | 286K | 156K | 421K | 883K | 883K |
| Current Liabilities | 80K | 233K | 303K | 373K | 413K | 131K | 215K | 875K | 1.7M | 2.1M | 2.4M | 450K | 450K |
| Per Share Data | |||||||||||||
| EPS | N/A | -0.01 | -0.06 | -0.01 | -0.01 | -0.23 | -0.05 | -0.10 | -0.11 | -0.05 | -0.03 | 0.02 | 0.02 |
| Owner EPS | N/A | -0.00 | 0.00 | -0.00 | -0.00 | -0.01 | -0.03 | -0.06 | -0.06 | -0.03 | -0.00 | 0.00 | 0.00 |
| Book Value | N/A | -0.04 | -0.28 | -0.05 | -0.07 | -0.15 | -0.09 | 0.11 | 0.01 | -0.04 | -0.07 | 0.07 | 0.07 |
| Cash Flow/Share | N/A | -0.00 | N/A | -0.00 | -0.00 | -0.01 | -0.03 | -0.05 | -0.04 | -0.02 | 0.02 | 0.01 | 0.02 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | N/A | 6.5M | 1.1M | 7.0M | 6.1M | 3.1M | 6.5M | 7.7M | 9.1M | 9.4M | 8.6M | 22.9M | 22.9M |
| Valuation | |||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 15.0 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 38.5 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 49.1 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 4.2 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.5 |
| FCF Yield | N/A | N/A | N/A | -4.1% | -1.5% | -6.1% | N/A | N/A | N/A | N/A | N/A | N/A | 2.6% |
| Market Cap | N/A | N/A | N/A | 291K | 1.2M | 628K | 0 | 0 | 0 | 0 | 0 | 0 | 6.9M |
| Avg. Price | N/A | N/A | N/A | 0.26 | 0.24 | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 |
| Year-End Price | N/A | N/A | N/A | 0.25 | 0.20 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 |
QHSLab, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
The company's 5-year average gross margin is 56.9%. Total shareholder yield (buybacks) is 13.9%.
QHSLab, Inc. (USAQ) reported earnings per share (EPS) of $0.02 in its most recent fiscal year.
QHSLab, Inc. (USAQ) has a return on equity (ROE) of 89.9%. This indicates the company generates strong returns for shareholders.
QHSLab, Inc. (USAQ) has a 5-year average gross margin of 56.9%. This high margin suggests strong pricing power and a potential competitive moat.
The Ledger Terminal provides 12 years of financial data for QHSLab, Inc. (USAQ), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
QHSLab, Inc. (USAQ) has a book value per share of $0.07, based on its most recent annual SEC filing.